v3.26.1

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 56,274	$ 63,707
Investments	219,688	215,799
Accounts receivable, net	29,350	35,448
Inventory, net	51,022	49,285
Prepaid expenses and other current assets	13,164	10,793
Short-term restricted cash	19	20
Total current assets	369,517	375,052
Property and equipment, net	24,376	24,146
Operating lease right-of-use assets, net	40,846	41,695
Long-term restricted cash	1,571	1,532
Intangible assets, net	14,104	15,124
Goodwill	317,761	317,761
Other long-term assets	14,190	8,773
Total assets	782,365	784,083
Current liabilities
Accounts payable	13,609	20,770
Accrued expenses	33,904	33,646
Deferred revenue, current	16,330	15,936
Operating lease liabilities, current	277	448
Other liabilities, current	1,235	2,031
Total current liabilities	65,355	72,831
Deferred revenue, non-current	3,554	3,929
Operating lease liabilities, non-current	59,004	56,592
Convertible senior notes, net, non-current	644,107	645,382
Other liabilities, non-current	7,979	0
Total liabilities	779,999	778,734
Commitments and contingencies
Stockholders’ equity
Preferred stock	0	0
Common stock	311	302
Additional paid-in capital	2,705,779	2,699,892
Accumulated other comprehensive (loss) income	(147)	457
Accumulated deficit	(2,703,577)	(2,695,302)
Total stockholders’ equity	2,366	5,349
Total liabilities and stockholders’ equity	$ 782,365	$ 784,083

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 10-Q